Methods and pharmaceutical preparations for normalizing blood pressure with (-)-hydroxycitric acid
AssigneeGlykon Technologies Group, LLC
InventorsDallas L. Clouatre, James M. Dunn
Life of this patent
Estimating the term…
Loading patent…
AssigneeGlykon Technologies Group, LLC
InventorsDallas L. Clouatre, James M. Dunn
Estimating the term…
A method whereby the blood pressure metabolism in an individual showing evidence of dysregulation is improved when that person receives an appropriate oral administration of (−)-hydroxycitric acid. The potassium salt of (−)-hydroxycitric acid is a preferred form of the compound, followed by the sodium salt, then by the amide and other derivatives of the acid. The regulation of blood pressure levels over any given period of time may be improved with a controlled release form of (−)-hydroxycitric acid. Controlled release can be used to provide a sustained and modulated amount of the active to the body as desired and therefore regulate the use of the compound as a hypotensive agent.
A method for treating or ameliorating hypertension or high blood pressure in individuals in need thereof which is comprised of administering orally an effective amount of (−)-hydroxycitric acid.
A method for treating or ameliorating hypertension or high blood pressure by lowering elevated insulin in individuals in need thereof which is comprised of administering orally an effective amount of (−)-hydroxycitric acid.
A method for treating or ameliorating hypertension or high blood pressure by lowering elevated glucocorticoid levels in individuals in need thereof which is comprised of administering orally an effective amount of (−)-hydroxycitric acid.
Dependencies are inferred from the claim text.